Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
Sulkowski, Mark S., Fessel, Walford J., Lazzarin, Adriano, Berenguer, Juan, Zakharova, Natalia, Cheinquer, Hugo, Côté, Pierre, Dieterich, Douglas, Gadano, Adrian, Matthews, Gail, Molina, Jean-Michel,Volume:
11
Language:
english
Journal:
Hepatology International
DOI:
10.1007/s12072-017-9788-z
Date:
March, 2017
File:
PDF, 621 KB
english, 2017